Covid-19: How AstraZeneca lost the vaccine PR war

  title={Covid-19: How AstraZeneca lost the vaccine PR war},
  author={Jacqui Wise},
  • J. Wise
  • Published 14 April 2021
  • Political Science
  • BMJ
AstraZeneca’s covid-19 vaccine has rarely been out of the news—and the headlines show no signs of abating. Jacqui Wise explains how miscommunication and politics created a nightmare for the company and the global vaccination effort 
Covid-19: Vaccine woes highlight vital role of traditional public health
It is shown that links with rare serious thrombotic events have only added to the AstraZeneca vaccine’s woes, and the mechanism is now also shared by the Johnson & Johnson vaccine.
COVID-19 Vaccine: Side Effects After the First Dose of the Oxford AstraZeneca Vaccine Among Health Professionals in Low-Income Country: Ethiopia
The immediate symptoms associated with taking the Oxford–AstraZeneca COVID-19 vaccine were assessed and severe symptoms were uncommon, but they were found to be a major reason why vaccine recipients did not recommend it to others and did not plan to take their second dose.
COVID-19 vaccine wastage in the midst of vaccine inequity: causes, types and practical steps
Effective supply chain management for the distribution of COVID19 vaccines in LMIC should be improved to overcome the ineffective practice of HIC donating ‘abouttoexpire’ vaccine doses to LMIC, which exacerbates the issue of overall wastage.
Side Effects Reported by Jordanian Healthcare Workers Who Received COVID-19 Vaccines
SE of COVID-19 vaccines distributed in Jordan are within the common range known so far for these vaccines, and systemic side effects in the form of fatigue, fatigue, myalgia, headache, and fever prevailed mainly after the first dose.
Communicating public health during COVID-19, implications for vaccine rollout
approaches to online public health messaging from a range of sources during COVID-19 are discussed, with a focus on official and non-official sources in the United Kingdom (UK), and issues for ongoing public health decisions are highlighted.
Trust, Science Education and Vaccines
  • M. Reiss
  • Education
    Science & education
  • 2022
The issue of trust in science has come to the fore in recent years. I focus on vaccines, first looking at what is known about trust in vaccines and then concentrating on whether what science
Taking a machine learning approach to optimize prediction of vaccine hesitancy in high income countries
The most relevant predictors were vaccination conspiracy beliefs, various paranoid concerns related to the pandemic, a general conspiracy mentality, COVID anxiety, high perceived risk of infection, low perceived social rank, lower age, lower income, and higher population density.
Global public health leadership: The vital element in managing global health crises
The principle aim of public health programs is to assess all risks, to identify underserved populations, and to initiate preventive measures, such as vaccines, non-pharmaceutical interventions and vector control, through collaboration and coordination with other agencies and organizations.